Loading…
Loading…
ZTS · NYSE · Healthcare
“While Zoetis demonstrates solid earnings power at $6.03 per share, the 19.3x multiple offers little margin of safety for this veterinary pharmaceutical enterprise.”
— In the voice of Graham
Analyze dividend yield, payout ratio, growth history, and sustainability for income-oriented investment decisions.
Market Cap
$51.72B
P/E Ratio
19.35
Forward P/E
—
EPS
$6.03
PEG Ratio
2.77
Book Value
$7.51
Dividend Yield
1.71%
Profit Margin
28.23%
ROE
80.25%
Use the interactive dividend analyzer with pre-loaded data for Zoetis Inc - Class A. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for ZTS: